D
NeuroSense Therapeutics Ltd. NRSN
$1.14 -$0.0301-2.57% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 12/31/2024 06/30/2024 09/30/2023
Revenue -- -- -- --
Total Other Revenue -- -- -- --
Total Revenue -- -- -- --
Cost of Revenue -- -- -- --
Gross Profit -- -- -- --
SG&A Expenses -- -- -- -47.14%
Depreciation & Amortization -- -- -- --
Other Operating Expenses -- -- -- --
Total Operating Expenses -- -- -- -17.53%
Operating Income -- -- -- 17.53%
Income Before Tax -- -- -- 6.72%
Income Tax Expenses -- -- -- --
Earnings from Continuing Operations -- -- -- 6.72%
Earnings from Discontinued Operations -- -- -- --
Extraordinary Item & Accounting Change -- -- -- --
Minority Interest in Earnings -- -- -- --
Net Income -- -- -- 6.72%
EBIT -- -- -- 17.53%
EBITDA -- -- -- 17.49%
EPS Basic -- -- -- 12.34%
Normalized Basic EPS -- -- -- -6.80%
EPS Diluted -- -- -- 12.34%
Normalized Diluted EPS -- -- -- -6.80%
Average Basic Shares Outstanding -- -- -- 16.31%
Average Diluted Shares Outstanding -- -- -- 16.31%
Dividend Per Share -- -- -- --
Payout Ratio -- -- -- --